Mike Rossi Joins ConcertAI as Chief Financial Officer, Bringing Deep Healthcare and Life Sciences Experience; Public Company Expertise
Deeply experienced finance executive joins the industry’s highest-growth AI SaaS healthcare and life sciences company
“Mike will be our first outside CFO since our founding in late 2017,” said Jeff Elton, PhD, CEO of ConcertAI. “We had the privilege of a very talented set of candidates with interest in ConcertAI. Our board and I are pleased with the finance expertise and company experiences Mike brings, all critical to assuring the next phase of our growth and long-term financial performance.”
ConcertAI presented at the 2023 J. P. Morgan Healthcare Conference and provided a set of unique views on the company progress over the last two to three years and the growth expected in 2023 through 2025. “Our business presentation highlighted the scope of partnerships we are forming to advanced needed new medicines to patients. Caris Life Sciences and BMS are but two public examples of these, with the clear implication that large-scale, complex, and transformative partnerships require leading infrastructure capabilities, reporting, insights and controls,” said Elton.
Recommended AI News: Talkwalker Reveals How Brands Can Leverage Consumer Intelligence to ‘Shape Tomorrow’ for Growth
“I have supported growth and value creation at multiple healthcare and life science companies. My focus has always been as a partner to company leadership, assuring growth in revenue, cash flow, and shareholder value through operating discipline, operating model transformations, and strategic acquisitions. I am excited to join the ConcertAI team to accelerate momentum with the winning team in place,”
Recommended AI News: Qrvey Ranked Among Top Embedded Business Intelligence Vendors by Dresner Advisory Services
[To share your insights with us, please write to sghosh@martechseries.com]
Comments are closed.